ATE490979T1 - Neueskollagen-ähnliches protein clac, dessen vorläufer und dafür kodierende gene - Google Patents
Neueskollagen-ähnliches protein clac, dessen vorläufer und dafür kodierende geneInfo
- Publication number
- ATE490979T1 ATE490979T1 AT01904413T AT01904413T ATE490979T1 AT E490979 T1 ATE490979 T1 AT E490979T1 AT 01904413 T AT01904413 T AT 01904413T AT 01904413 T AT01904413 T AT 01904413T AT E490979 T1 ATE490979 T1 AT E490979T1
- Authority
- AT
- Austria
- Prior art keywords
- clac
- precursor
- genes coding
- protein
- new collagen
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 102400000303 Collagen-like Alzheimer amyloid plaque component Human genes 0.000 title abstract 2
- 101800001122 Collagen-like Alzheimer amyloid plaque component Proteins 0.000 title abstract 2
- 101710137510 Saimiri transformation-associated protein Proteins 0.000 title abstract 2
- 239000002243 precursor Substances 0.000 title abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 101710092817 Collagen alpha-1(XXV) chain Proteins 0.000 abstract 1
- 102100031576 Collagen alpha-1(XXV) chain Human genes 0.000 abstract 1
- 101000940249 Mus musculus Collagen alpha-1(XXV) chain Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP0000788 | 2000-02-14 | ||
| PCT/JP2001/001014 WO2001058943A1 (fr) | 2000-02-14 | 2001-02-14 | Nouvelle proteine clac du type collagene, precurseur de ladite proteine, et genes codant pour cette proteine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE490979T1 true ATE490979T1 (de) | 2010-12-15 |
Family
ID=11735679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01904413T ATE490979T1 (de) | 2000-02-14 | 2001-02-14 | Neueskollagen-ähnliches protein clac, dessen vorläufer und dafür kodierende gene |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US7514542B2 (de) |
| EP (1) | EP1270588B1 (de) |
| JP (1) | JP4249927B2 (de) |
| CN (1) | CN1241940C (de) |
| AT (1) | ATE490979T1 (de) |
| AU (1) | AU2001232275A1 (de) |
| CA (1) | CA2400117C (de) |
| DE (1) | DE60143608D1 (de) |
| WO (1) | WO2001058943A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1288226A1 (de) * | 2001-09-03 | 2003-03-05 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Modifizierung der Geneexpression der Mitglieder von "Toll"-ähnlicher Rezeptorfamilie zur Beeinflussung der Neurodegeneration und der Neuroprotektion im menschlichen Zentralnervensystem |
| US7993863B2 (en) * | 2002-03-19 | 2011-08-09 | Children's Medical Center Corporation | Methods for diagnosis and prognosis of cancer |
| JP2005073592A (ja) * | 2003-09-01 | 2005-03-24 | Yukiguni Maitake Co Ltd | マイタケ由来のレクチンをコードする遺伝子 |
| CN103772560B (zh) * | 2012-10-22 | 2017-03-01 | 中国石油化工股份有限公司 | 一种纤维用超高分子量聚乙烯树脂及其制备方法 |
| US8989053B1 (en) * | 2013-11-29 | 2015-03-24 | Fedex Corporate Services, Inc. | Association management in a wireless node network |
| KR101873247B1 (ko) * | 2016-08-22 | 2018-08-02 | 대한민국 | 치매진단용 자가항체 바이오마커 및 이를 이용한 치매진단 방법 |
| EP3658172A4 (de) | 2017-07-25 | 2021-05-05 | TrueBinding, Inc. | Behandlung von krebs durch blockierung der interaktion von tim-3 und seinem liganden |
| US11180541B2 (en) * | 2017-09-28 | 2021-11-23 | Geltor, Inc. | Recombinant collagen and elastin molecules and uses thereof |
| CN108061795B (zh) * | 2017-11-24 | 2020-02-18 | 大连医科大学 | 提高检测灵敏度的蛋白质免疫印迹法 |
| CN113711036B (zh) | 2019-01-30 | 2025-03-18 | 真和制药有限公司 | 抗gal3抗体及其用途 |
| CN116157151A (zh) | 2020-05-26 | 2023-05-23 | 真和制药有限公司 | 通过阻断半乳凝素-3治疗炎性疾病的方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2311201A1 (en) * | 1999-08-05 | 2001-02-05 | Genset S.A. | Ests and encoded human proteins |
-
2001
- 2001-02-14 CA CA002400117A patent/CA2400117C/en not_active Expired - Lifetime
- 2001-02-14 AU AU2001232275A patent/AU2001232275A1/en not_active Abandoned
- 2001-02-14 EP EP01904413A patent/EP1270588B1/de not_active Expired - Lifetime
- 2001-02-14 US US10/203,561 patent/US7514542B2/en not_active Expired - Lifetime
- 2001-02-14 AT AT01904413T patent/ATE490979T1/de not_active IP Right Cessation
- 2001-02-14 CN CNB018077323A patent/CN1241940C/zh not_active Expired - Lifetime
- 2001-02-14 WO PCT/JP2001/001014 patent/WO2001058943A1/ja not_active Ceased
- 2001-02-14 JP JP2001558090A patent/JP4249927B2/ja not_active Expired - Lifetime
- 2001-02-14 DE DE60143608T patent/DE60143608D1/de not_active Expired - Lifetime
-
2008
- 2008-12-05 US US12/329,218 patent/US20100004433A1/en not_active Abandoned
- 2008-12-05 US US12/329,171 patent/US7888076B2/en not_active Expired - Fee Related
-
2011
- 2011-01-06 US US12/985,917 patent/US8173775B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20110137013A1 (en) | 2011-06-09 |
| US20040250304A1 (en) | 2004-12-09 |
| US8173775B2 (en) | 2012-05-08 |
| US7888076B2 (en) | 2011-02-15 |
| US20090280530A1 (en) | 2009-11-12 |
| EP1270588A4 (de) | 2003-07-30 |
| CN1422280A (zh) | 2003-06-04 |
| CA2400117A1 (en) | 2001-08-16 |
| CN1241940C (zh) | 2006-02-15 |
| US7514542B2 (en) | 2009-04-07 |
| CA2400117C (en) | 2009-11-17 |
| US20100004433A1 (en) | 2010-01-07 |
| EP1270588A1 (de) | 2003-01-02 |
| DE60143608D1 (de) | 2011-01-20 |
| EP1270588B1 (de) | 2010-12-08 |
| WO2001058943A1 (fr) | 2001-08-16 |
| JP4249927B2 (ja) | 2009-04-08 |
| AU2001232275A1 (en) | 2001-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1541686A4 (de) | Antikörperkonstruktion unter verwendung einer mrl/lpr-maus | |
| WO2005061545A3 (en) | Nogoa antibodies for the treatment of alzheimer disease | |
| DE50210317D1 (de) | Peptid zur diagnose und therapie der alzheimer-demenz | |
| ATE475432T1 (de) | Arzneimittel für herzversagen | |
| AT500379B1 (de) | Tau-proteine | |
| ATE229072T1 (de) | Für den vorläufer des für die tumorabstossung verantwortlichen antigens mage-3 kodierendes, isoliertes nukleinsäuremolekül und seine verwendung | |
| CY1110371T1 (el) | ΑΝΑΣΥΝΔΥΑΣΜΕΝΑ ΑΝΤΙΣΩΜΑΤΑ ΕΠΙΛΕΚΤΙΚΑ ΤΩΝ ΑΚΡΩΝ ΤΟΥ β-ΑΜΥΛΟΕΙΔΟΥΣ, DNA ΠΟΥ ΤΑ ΚΩΔΙΚΟΠΟΙΟΥΝ ΚΑΙ ΜΕΘΟΔΟΙ ΧΡΗΣΕΩΣ ΤΟΥΣ | |
| ATE466093T1 (de) | Rekombinanter adeno-assoziierter virusvektor zur behandlung von morbus alzheimer | |
| DE602004011770D1 (de) | Fusionsproteine | |
| DE602004026898D1 (de) | Zusammensetzungen für die diagnose und therapie von erkrankungen, die im zusammenhang mit einer anomalen expression von futrinen (r-spondinen) stehen | |
| DE60143608D1 (de) | Neueskollagen-ähnliches protein clac, dessen vorläufer und dafür kodierende gene | |
| ATE209684T1 (de) | Dna-sequenzen für matrix-metallproteasen, ihre herstellung und verwendung | |
| AU2002330215A1 (en) | Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease | |
| DK0966533T3 (da) | Aktivitetsafhængig neurotrof faktor III (ADNF III). | |
| ATE271603T1 (de) | Identifizierungsverfahren für substanzen die an das pyk2 polypeptid binden | |
| WO2007021886A3 (en) | Truncated memapsin 2 for use for treating alzheimer's disease | |
| EA200400812A1 (ru) | Секретируемый белок | |
| ATE395602T1 (de) | Verwendung von hmgb-proteinen und dafür codierenden nukleinsäuren | |
| GEP20043386B (en) | β -Amyloid Peptide-Binding Proteins and Polynucleotides Encoding the Same | |
| EA200501711A1 (ru) | Семейство секретируемых белков | |
| ATE314861T1 (de) | Verwendung von antikörper gegen mag zur behandlung ischämischer schlaganfälle | |
| EE200000478A (et) | Peptiid, seda kodeeriv geen, diagnostiline reagent ja diagnostiline reaktiivikomplekt ning vaktsiinkasutamiseks riketsioosi ravis | |
| DE60321443D1 (de) | Screening-verfahren für eine prophylaktische und therapeutische Substanz für eine Nierenerkrankung | |
| ATE401402T1 (de) | Mit syndekan interagierende proteine und deren verwendung | |
| ATE512981T1 (de) | Identifizierung von ses-3 (spr-5) aus c. elegans sowie dessen verwendungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |